AU2003204403A1 - Macrophage Derived Chemokine (MDC) as an Anti-viral Agent for the Treatment and Prevention of Lentivirus Infections - Google Patents

Macrophage Derived Chemokine (MDC) as an Anti-viral Agent for the Treatment and Prevention of Lentivirus Infections

Info

Publication number
AU2003204403A1
AU2003204403A1 AU2003204403A AU2003204403A AU2003204403A1 AU 2003204403 A1 AU2003204403 A1 AU 2003204403A1 AU 2003204403 A AU2003204403 A AU 2003204403A AU 2003204403 A AU2003204403 A AU 2003204403A AU 2003204403 A1 AU2003204403 A1 AU 2003204403A1
Authority
AU
Australia
Prior art keywords
mdc
prevention
treatment
viral agent
derived chemokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003204403A
Inventor
Anthony L Devico
Robert C Gallo
Alfredo Garzino-Demo
Phillip D Markham
Ranajit Paal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Biotechnology Institute UMBI
Biomerieux Inc
Original Assignee
University of Maryland Biotechnology Institute UMBI
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Biotechnology Institute UMBI, Biomerieux Inc filed Critical University of Maryland Biotechnology Institute UMBI
Publication of AU2003204403A1 publication Critical patent/AU2003204403A1/en
Abandoned legal-status Critical Current

Links

AU2003204403A 1997-09-16 2003-05-28 Macrophage Derived Chemokine (MDC) as an Anti-viral Agent for the Treatment and Prevention of Lentivirus Infections Abandoned AU2003204403A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/931764 1997-09-16

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU95704/98A Division AU763095B2 (en) 1997-09-16 1998-09-16 Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infections

Publications (1)

Publication Number Publication Date
AU2003204403A1 true AU2003204403A1 (en) 2003-06-26

Family

ID=

Similar Documents

Publication Publication Date Title
IL139002A0 (en) Compositions for the treatment of hiv and other viral infections
AU5362696A (en) Compounds and methods for the dectection of t. cruzi infection
AU4205789A (en) Method and composition for the treatment and prevention of viral infections
AU6445694A (en) Differential- to single-ended cmos converter
AU4813197A (en) Compositions and methods for treating viral infections
WO1997022346A3 (en) Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
AU5254696A (en) Reduced toxicity compositions and methods for treating hiv infections
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU4757093A (en) Antinephrotic syndrome agent
AU1556497A (en) Agents for the treatment and prevention of aids
AU5758594A (en) Treatment of viral infections
EP0643074A3 (en) Viral infection and proliferation inhibitors.
AU6776994A (en) Direct lysis buffer and the detection of hiv-1 plasma viremia
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
AU2817897A (en) Qualified burst buffer
AU5798996A (en) Adnaz, compositions and processes
AU2177697A (en) Preventive and remedy for viral infections
AU1907995A (en) Active muffler
AU6391994A (en) Compounds active against aids and related infections
AU675568B2 (en) Antitumor agent
AU2003204403A1 (en) Macrophage Derived Chemokine (MDC) as an Anti-viral Agent for the Treatment and Prevention of Lentivirus Infections
AU1805799A (en) Compounds and methods for the detection and prevention of (t. cruzi) infection
AU1364497A (en) An antibacterial or antiviral pharmaceutical composition and preparation thereof
AU4270499A (en) Purified (alteromonas macleodii) polysaccharide and its uses
AU6130194A (en) 1,2-dithiole-3-thiones for the treatment of reverse transcriptase-dependent viral infections